✦ LIBER ✦

A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer

✍ Scribed by Ian Olver; Margaret Davy; Diana Lüftner; So-Hyang Park; Merrill Egorin; Andrew Ellis; Lorraine Webster

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and escalating doses of paclit

✍ Mario Nardi; Salvatore De Marco; Alessandra Fabi; Alessandra Aloe; Elena Magnani 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 70 KB

Phase II study of paclitaxel combined wi

✍ N. Baize; A. Abakar-Mahamat; N. Mounier; F. Berthier; F. X. Caroli-Bosc 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 276 KB

A phase II study of etoposide combined w

✍ Claes Tropé; Janne Kærn; Ignace Vergote; Svein Vossli 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 246 KB

A phase I study of paclitaxel, cisplatin

✍ Takuo Hara; Kenji Omura; Makoto Hirano; Yasuyuki Asada; Yoshinori Munemoto; Juni 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 130 KB

A phase II trial of weekly 1-hour paclit

✍ Howard D. Homesley; Nathan P. Meltzer; Lucybeth Nieves; Luis Vaccarello; George 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 199 KB

Doublet regimen of cisplatin plus doceta

✍ Takashi Seto; Yoriko Takezako; Hiroko Nakamura; Kayo Takeda; Fumiko Inoue; Hiros 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 193 KB